Processa Pharmaceuticals, Inc.

Q4 2024 13F Holders

Symbol
PCSA
CUSIP
74275C304
Type
Equity
Class
COM SHS
Num filings
9
Total reported value, excl. options
$87.5 k
Manager Report Date Value ($000) Shares Option Type